Cohort profile: the Themba Lethu Clinical Cohort, Johannesburg, South Africa.
about
Imputing HIV treatment start dates from routine laboratory data in South Africa: a validation studyImplementation and Operational Research: Risk Charts to Guide Targeted HIV-1 Viral Load Monitoring of ART: Development and Validation in Patients From Resource-Limited Settings.Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa.Incidence and predictors of herpes zoster among antiretroviral therapy-naïve patients initiating HIV treatment in Johannesburg, South AfricaCD4 criteria improves the sensitivity of a clinical algorithm developed to identify viral failure in HIV-positive patients on antiretroviral therapy.Incidence of pregnancy after initiation of antiretroviral therapy in South Africa: a retrospective clinical cohort analysis.Attrition through multiple stages of pre-treatment and ART HIV care in South AfricaThe relation between efavirenz versus nevirapine and virologic failure in Johannesburg, South Africa.Incident pregnancy and time to death or AIDS among HIV-positive women receiving antiretroviral therapyTreatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort studyThe impact of choice of NNRTI on short-term treatment outcomes among HIV-infected patients prescribed tenofovir and lamivudine in Johannesburg, South Africa.Incidence and predictors of recovery from anaemia within an HIV-infected South African Cohort, 2004-2010.Comparison of pharmacy-based measures of adherence to antiretroviral therapy as predictors of virological failureKaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.A hospital-based tuberculosis focal point to improve tuberculosis care provision in a very high burden setting.CD4+ gain percentile curves for monitoring response to antiretroviral therapy in HIV-infected adults.Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled TrialBrief Report: Does Most Mortality in Patients on ART Occur in Care or After Lost to Follow-Up? Evidence From the Themba Lethu Clinic, South Africa.Predictive and prognostic properties of TB-LAM among HIV-positive patients initiating ART in Johannesburg, South Africa.Low-Cost Method to Monitor Patient Adherence to HIV Antiretroviral Therapy Using Multiplex Cathepsin ZymographyTreatment outcomes of HIV-positive patients on first-line antiretroviral therapy in private versus public HIV clinics in Johannesburg, South AfricaThe feasibility of using screening criteria to reduce clinic visits for stable patients on antiretroviral therapy in South Africa.The interplay between CD4 cell count, viral load suppression and duration of antiretroviral therapy on mortality in a resource-limited setting.Treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics across Gauteng and Mpumalanga, South Africa.Prevalence of common vitamin D receptor gene polymorphisms in HIV-infected and uninfected South AfricansKaposi sarcoma-associated herpes virus and response to antiretroviral therapy: a prospective study of HIV-infected adultsTenofovir use and pregnancy among women initiating HAARTSame-Day CD4 Testing to Improve Uptake of HIV Care and Treatment in South Africa: Point-of-Care Is Not EnoughImpact of nutritional supplementation on immune response, body mass index and bioelectrical impedance in HIV-positive patients starting antiretroviral therapy.Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART RegimenImpact of three empirical anti-tuberculosis treatment strategies for people initiating antiretroviral therapy.Increases in regimen durability associated with the introduction of tenofovir at a large public-sector clinic in Johannesburg, South AfricaCan Short-Term Use of Electronic Patient Adherence Monitoring Devices Improve Adherence in Patients Failing Second-Line Antiretroviral Therapy? Evidence from a Pilot Study in Johannesburg, South Africa.Insights into Adherence among a Cohort of Adolescents Aged 12-20 Years in South Africa: Reported Barriers to Antiretroviral Treatment.Citizenship status and engagement in HIV care: an observational cohort study to assess the association between reporting a national ID number and retention in public-sector HIV care in Johannesburg, South AfricaPoor CD4 recovery and risk of subsequent progression to AIDS or death despite viral suppression in a South African cohort.Treatment outcomes of over 1000 patients on second-line, protease inhibitor-based antiretroviral therapy from four public-sector HIV treatment facilities across Johannesburg, South Africa.Cohort profile: the Right to Care Clinical HIV Cohort, South Africa.Cervical cancer risk and impact of Pap-based screening in HIV-positive women on antiretroviral therapy in Johannesburg, South Africa.Tenofovir stock shortages have limited impact on clinic- and patient-level HIV treatment outcomes in public sector clinics in South Africa.
P2860
Q31155083-DF08B5FF-89CD-4C90-8FF6-2A64F4DD2918Q33576031-4169742C-42BB-4D85-951F-DCDF47CE4D11Q33733440-48D6F172-017E-4575-A517-D905AD3674DBQ33883111-37801CC5-C0B0-4C22-99E7-2BC215309CE0Q34195328-41031A67-F807-455A-970E-97026967FE5BQ34331885-8C45C06E-3C87-4450-94CB-401AF02CC1EEQ34374074-24FD3DFE-CDA7-4FC3-A2FA-6BDBF9F16B6CQ34433397-D4E4A8CC-F8A0-4576-A13F-18EBE52A4E1CQ34631738-1C4CACAC-F906-4144-9AAD-AAED9063F8FEQ34765704-115E4D04-5254-43AB-8F74-6CA0F6C62623Q34938054-BFD5B9B3-87EA-4308-B99C-239DC64D3ED3Q35110406-140046BD-5ABF-4B8F-A4D4-91794C15EDD1Q35370804-840ACEA6-A592-4C1E-BC23-E677421C4B2BQ35557475-A8CC8FCE-A573-48FE-A887-E0E8757DBF86Q35719006-6BA3B361-7F6F-4362-9651-380D2902D2E7Q35804785-BE36267F-DB20-49FA-A113-CD587AD50625Q36013294-63E7B262-9FB9-4DBA-91BE-1DA4AD2C01AAQ36228325-50EEC86E-9A31-40BA-B42F-337D3E8A56FCQ36275193-356C9853-10AF-49E4-BA5D-6FFB67B8D97FQ36460146-00E46FCE-2ECD-4E92-BE2D-3DCF1AB72E83Q36729112-80CD1470-694B-4867-B5E6-525E6D8806EDQ36746580-312595FF-2748-40FC-AB18-474B143E92F7Q36763062-B937BBB7-279E-4FA8-AD25-993078B75D64Q36842096-5E07EAEB-92DF-4AF1-8B4E-AEDF2D3EEA4AQ36874968-5F9B2B1A-CBE0-49FF-9B20-77D9401B46AAQ37015398-8B1EE451-E782-4C98-A064-C65D5E007288Q37051627-BD484153-D050-4642-81AE-6A0A3B6E7C7FQ37061972-47A6B7A1-446C-4657-9C94-63BE8A42E093Q37113070-4D5861B3-C0F5-48EF-8390-A6C7ED65A5A9Q37166538-77423281-B5C2-46EA-9C62-83F3B0ECD1DFQ37255263-04E081A3-99FC-4F6D-9D6D-A0BFC5F599B2Q37330398-E2F40C5E-85F3-41A8-B6D4-6EBF821C99F0Q37348464-6EE31825-79DB-492F-A7E2-A7C6E6648E6AQ37404721-FD7FCE2C-53CA-4566-8C47-F6C627FB5E65Q37612096-E3581F39-C9A4-45B5-8292-34DEEBC211FDQ37617342-89142976-04BC-491D-B6D5-C38417C9C529Q37619925-4F44F467-8882-4AAA-BC55-5D66474465BFQ38672416-0D5F1728-188C-4D71-B009-EC25B51F1803Q38821448-EF01F413-A93E-4F8E-9FAF-5EDE0B29767BQ39174707-59193B09-07AD-47CE-AC14-978A466ACAAC
P2860
Cohort profile: the Themba Lethu Clinical Cohort, Johannesburg, South Africa.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cohort profile: the Themba Lethu Clinical Cohort, Johannesburg, South Africa.
@en
type
label
Cohort profile: the Themba Lethu Clinical Cohort, Johannesburg, South Africa.
@en
prefLabel
Cohort profile: the Themba Lethu Clinical Cohort, Johannesburg, South Africa.
@en
P2093
P2860
P50
P356
P1476
Cohort profile: the Themba Lethu Clinical Cohort, Johannesburg, South Africa
@en
P2093
A Patrick MacPhail
Daniel Westreich
Ian M Sanne
Pappie Majuba
P2860
P304
P356
10.1093/IJE/DYS029
P577
2012-03-20T00:00:00Z